Universal Biosensors Inc
(ASX:UBI) CEO Paul Wright presents at ASX Spotlight Series in New York.
The medical diagnostics company’s presentation outlines the investment case for the group, its broad product pipeline and opportunities.
Mr Wright also discusses how Universal Biosensors’ plans to move up the value chain and target large and growing segments.
Introducing the company Mr Wright says, “Overall we are targeting a large and growing point of care diagnostics market with a novel technology platform based on electrochemistry, electrochemical sensing.
We validated that technology and the power of that technology and our organisational capability through partnering deals with two world leaders, in Johnson & Johnson and Siemens Healthcare...
We have growing revenues... and we have a pipeline of products... which will make us a diagnostics company rather than simply a supplier to larger entities.”
